Eliks Małgorzata, Gajewska Ewa
Chair and Clinic of the Developmental Neurology, Poznan University of Medical Sciences, Poznań, Poland.
Doctoral School, Poznan University of Medical Sciences, Poznań, Poland.
Front Neurol. 2022 Sep 14;13:927502. doi: 10.3389/fneur.2022.927502. eCollection 2022.
According to the recommendations of the American Academy of Pediatrics, the surveillance of motor development should accompany systematic appointments with medical professionals in infancy and early childhood. One of the standardized tools for evaluating motor development is the Alberta Infant Motor Scale (AIMS). This paper aims to present assumptions and psychometric properties of the AIMS, the methodology of assessment of an infant's performance with the AIMS, and research on the validation and standardization of the AIMS as well as the use of the scale as an outcome measure. We conducted a non-systematic literature review using three electronic databases: PubMed, Scopus, and Embase (from June 1992 to February 2022). We included original research with a full-text manuscript in English. No geographical restrictions were applied. The search terms "alberta infant motor scale" AND "reliability" OR "validity" and "alberta infant motor scale" AND "norms" OR "reference" OR "standardization" were used for literature review on the validation and standardization of the AIMS in other non-Canadian populations. This narrative review also focuses on how the AIMS is applied as an outcome measure in research by presenting studies on the AIMS conducted over the last decade. Our review found that the AIMS is widely used for both research and clinical purposes. The AIMS has been used as an outcome measure in both interventional and observational studies conducted on both neurotypical infants and those with conditions affecting motor development. The advantages of the scale are its infant-friendliness, time duration of the examination, and relative ease of application for an examiner. The scale has been validated and standardized in many countries.
根据美国儿科学会的建议，在婴儿期和幼儿期进行系统的医学专业人员预约时，应同时监测运动发育情况。评估运动发育的标准化工具之一是艾伯塔婴儿运动量表（AIMS）。本文旨在介绍AIMS的假设和心理测量特性、使用AIMS评估婴儿表现的方法，以及关于AIMS的验证、标准化研究，以及该量表作为结果指标的应用。我们使用三个电子数据库进行了非系统性文献综述：PubMed、Scopus和Embase（从1992年6月至2022年2月）。我们纳入了英文全文手稿的原创研究。未设置地理限制。搜索词“艾伯塔婴儿运动量表”和“信度”或“效度”以及“艾伯塔婴儿运动量表”和“常模”或“参考值”或“标准化”用于对其他非加拿大人群中AIMS的验证和标准化进行文献综述。本叙述性综述还通过介绍过去十年中关于AIMS的研究，重点关注AIMS在研究中作为结果指标的应用。我们的综述发现，AIMS广泛用于研究和临床目的。AIMS已被用作对发育正常的婴儿以及患有影响运动发育疾病的婴儿进行的干预性和观察性研究的结果指标。该量表的优点是对婴儿友好、检查所需时间以及检查者相对易于应用。该量表已在许多国家得到验证和标准化。
